A public forum will be held on Tuesday, November 15th at Nicholson Hall, 9 Harris Street, Newburyport, from 7 to 9 PM.  Come hear experts discuss the safety implications of Seabrook's request to operate until 2050.  See flyer for more details.

C-10 hosted a public forum "What Happened At Fukushima - Why It Can Happen Here" on June 16, 2011 at  the Boston Public Library.  In the following video, nuclear engineers Dave Lochbaum and Arnie Gunderson walk through step-by-step the events of the Fukushima meltdown to illustrate the "points of vulnerability" in US plants.  According to the experts, many of these vulnerabilities have not been adequately addressed by the NRC to date. 

Watch the Video

YouTube video clips from the June 16, 2011 public forum.

Fairewinds Associates, Inc. provides frequent status updates on Fukushima.

For information concerning how nuclear plants operate and what is occurring in the various nuclear accident scenarios in Japan, The Union Of Concerned Scientists provide reliable updates on their website.

For the most reliable information on potassium iodine (KI) we encourage you to go the the American Thyroid Association website.

Local pharmacies carry KI.

NextEra, owners of the Seabrook nuclear power plant in New Hampshire, have announced plans to request an operating license renewal 20 years before the expiration of the current license.  At a press conference on August 18, 2010, C-10 Foundation announced the formation of a coalition of local, regional, and national groups who filed a Petition for Rulemaking to the Nuclear Regulatory Commission.  The Petition requests the NRC to change its rule to require the license extension process begin no more than 10 years before the expiration date.

C-10 Foundation has not found evidence that NextEra has provided in their application proof that the reactor can be safely operated or managed to assure public safety until 2050.  C-10's Statement on Submerged Cables at Seabrook provides an example of our opposition and has called upon the NRC to suspend its current review.